NCT02310477View on ClinicalTrials.gov

Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting

CompletedOBSERVATIONAL
Enrollment

704

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

December 31, 2014

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

regorafenib

regorafenib for all groups

Trial Locations (1)

59020

Centre Oscar Lambret, Lille

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Centre Oscar Lambret

OTHER